PW
Park West Asset Management LLC
13F filer · CIK 0001386928Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$1.47BU.S. long equity reported on 13F
Positions4612 new · 14 closed
Net flow last quarter-$127MBuys minus sells
Top 10 positions weight44.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202646 positions | |||||
| $92.1M | 6.28% | 0.15% | -42.7% | Q2 2019 | |
| $77.4M | 5.27% | 0.00% | -12.5% | Q4 2023 | |
| $70.1M | 4.78% | 0.93% | +24.6% | Q1 2026 | |
| $68.6M | 4.68% | 0.00% | -32.6% | Q2 2025 | |
| $67.4M | 4.59% | Not reported | New | Q2 2026 | |
| $61.7M | 4.20% | 0.21% | -44.3% | Q3 2025 | |
| $60M | 4.09% | 1.00% | +1.2% | Q1 2025 | |
| $58.7M | 4.00% | 0.66% | -11.5% | Q3 2025 | |
| $53.2M | 3.62% | 2.77% | -30.6% | Q1 2021 | |
| $49.5M | 3.37% | 1.29% | -14.0% | Q4 2025 | |
| $46.4M | 3.16% | 0.91% | -9.8% | Q1 2026 | |
| $45.7M | 3.11% | 0.75% | +121.3% | Q2 2022 | |
| $44.1M | 3.01% | 2.30% | Not reported | Q4 2023 | |
| $43.1M | 2.94% | 6.07% | +60.5% | Q2 2025 | |
| $40.7M | 2.77% | 1.07% | +25.3% | Q2 2023 | |
| $40M | 2.72% | Not reported | Not reported | Q4 2022 | |
| $39.8M | 2.71% | 0.05% | New | Q2 2026 | |
| $38M | 2.59% | 1.39% | +234.2% | Q1 2026 | |
| $36.6M | 2.50% | 2.21% | -6.7% | Q3 2025 | |
| $35.8M | 2.44% | 0.24% | -42.6% | Q1 2026 | |
| $31.6M | 2.15% | 0.04% | +11.0% | Q4 2025 | |
| $31.5M | 2.15% | Not reported | New | Q2 2026 | |
| $27.3M | 1.86% | 0.91% | +671.7% | Q1 2026 | |
| $25.6M | 1.74% | 0.01% | -46.7% | Q4 2019 | |
| $25M | 1.70% | 0.20% | New | Q2 2026 | |
| $22.5M | 1.53% | 0.57% | -47.8% | Q1 2026 | |
| $21.9M | 1.49% | 1115000.00% | Not reported | Q4 2021 | |
| $21.7M | 1.48% | 0.41% | New | Q2 2026 | |
| $20.5M | 1.40% | Not reported | -24.4% | Q1 2024 | |
| $20.3M | 1.39% | 0.03% | +18.8% | Q2 2024 | |
| $18.2M | 1.24% | 0.09% | Not reported | Q1 2019 | |
| $18.1M | 1.23% | 0.07% | New | Q2 2026 | |
| $14.3M | 0.97% | 1.97% | Not reported | Q3 2025 | |
| $13M | 0.88% | 0.08% | -23.1% | Q4 2024 | |
| $11.2M | 0.76% | Not reported | -43.7% | Q2 2025 | |
| $10.3M | 0.70% | 0.01% | Not reported | Q1 2022 | |
| $10.2M | 0.70% | 0.08% | -66.9% | Q3 2025 | |
| $9.8M | 0.67% | 0.06% | -4.2% | Q3 2025 | |
| $9.63M | 0.66% | 0.43% | -55.5% | Q1 2025 | |
| $9.53M | 0.65% | 0.32% | New | Q2 2026 | |
| $9.34M | 0.64% | 0.09% | -8.0% | Q1 2026 | |
| $5.96M | 0.41% | 0.10% | -71.1% | Q3 2025 | |
| $3.36M | 0.23% | 0.14% | -62.6% | Q3 2019 | |
| $3.02M | 0.21% | Not reported | Not reported | Q1 2026 | |
| $82.6K | 0.01% | Not reported | Not reported | Q3 2023 | |
| $41.2K | 0.00% | Not reported | Not reported | Q1 2026 | |
| Q1 2026Reported May 15, 202648 positions | |||||
| $82M | 6.96% | 0.00% | -19.0% | Q2 2025 | |
| $77.3M | 6.56% | 0.00% | +23.3% | Q4 2023 | |
| $64.9M | 5.51% | 0.27% | +1.0% | Q2 2019 | |
| $57.3M | 4.86% | 0.37% | -10.5% | Q3 2025 | |
| $52.1M | 4.42% | 0.74% | New | Q1 2026 | |
| $51.1M | 4.34% | 0.75% | +117.2% | Q3 2025 | |
| $48.9M | 4.15% | 1.50% | +398.8% | Q4 2025 | |
| $36.5M | 3.10% | 4.10% | +0.9% | Q1 2021 | |
| $36.5M | 3.09% | 3.86% | +37.3% | Q2 2025 | |
| $36.3M | 3.08% | 1.18% | New | Q1 2026 | |
| $36.2M | 3.07% | 0.08% | +64.3% | Q4 2025 | |
| $35.7M | 3.03% | Not reported | -16.8% | Q1 2024 | |
| $33.4M | 2.84% | 0.99% | +17.8% | Q1 2025 | |
| $29.6M | 2.51% | 0.41% | New | Q1 2026 | |
| $29.2M | 2.48% | 0.85% | -29.4% | Q2 2023 | |
| $28.2M | 2.40% | 0.40% | +220.5% | Q4 2023 | |
| $25.3M | 2.15% | 0.03% | +36.3% | Q4 2025 | |
| $24.5M | 2.08% | 1.09% | New | Q1 2026 | |
| $22.7M | 1.92% | 0.00% | +100.0% | Q4 2025 | |
| $21.6M | 1.84% | Not reported | -19.8% | Q2 2025 | |
| $21.3M | 1.80% | 2.39% | +10.8% | Q3 2025 | |
| $20.3M | 1.72% | 0.02% | -32.7% | Q4 2019 | |
| $19.7M | 1.67% | 0.34% | +3.1% | Q2 2022 | |
| $18M | 1.53% | 0.29% | -12.3% | Q3 2025 | |
| $17M | 1.44% | 0.35% | -41.4% | Q3 2025 | |
| $16.8M | 1.43% | 0.02% | -20.0% | Q2 2024 | |
| $15.5M | 1.31% | 0.29% | New | Q1 2026 | |
| $15.5M | 1.31% | 0.96% | +25.8% | Q1 2025 | |
| $15.2M | 1.29% | 0.08% | -75.6% | Q3 2025 | |
| $15.2M | 1.29% | Not reported | New | Q1 2026 | |
| $13.9M | 1.18% | 0.11% | -44.5% | Q4 2024 | |
| $12.7M | 1.08% | 0.01% | +20.1% | Q4 2025 | |
| $12.3M | 1.04% | 1.97% | Not reported | Q3 2025 | |
| $11.8M | 1.01% | 0.91% | +70.0% | Q4 2025 | |
| $11.4M | 0.97% | 0.27% | +19.5% | Q3 2020 | |
| $11.3M | 0.96% | 0.21% | -5.2% | Q4 2025 | |
| $7.73M | 0.66% | 0.09% | New | Q1 2026 | |
| $7.67M | 0.65% | 0.07% | +21.1% | Q3 2025 | |
| $7.59M | 0.64% | 0.38% | -57.7% | Q3 2019 | |
| $7.11M | 0.60% | 0.42% | New | Q1 2026 | |
| $6.93M | 0.59% | 0.71% | -53.2% | Q2 2022 | |
| $6.36M | 0.54% | 0.11% | -74.5% | Q2 2013 | |
| $4.89M | 0.42% | 0.66% | New | Q1 2026 | |
| $2.99M | 0.25% | Not reported | New | Q1 2026 | |
| $2.2M | 0.19% | 0.12% | New | Q1 2026 | |
| $1.33M | 0.11% | 0.00% | New | Q1 2026 | |
| $150K | 0.01% | Not reported | Not reported | Q3 2023 | |
| $36.2K | 0.00% | Not reported | New | Q1 2026 | |
| Q4 2025Reported Feb 17, 202647 positions | |||||
| $110M | 9.15% | 0.00% | +17.3% | Q2 2025 | |
| $70.6M | 5.86% | Not reported | +29.4% | Q1 2024 | |
| $69.4M | 5.77% | 0.00% | +5.3% | Q4 2023 | |
| $59.3M | 4.93% | 0.27% | -8.5% | Q2 2019 | |
| $46.1M | 3.83% | 4.07% | +131.3% | Q1 2021 | |
| $44.5M | 3.70% | 0.41% | +364.4% | Q3 2025 | |
| $41.7M | 3.46% | 0.32% | -39.8% | Q3 2025 | |
| $39M | 3.24% | 0.10% | -36.3% | Q2 2025 | |
| $37.5M | 3.11% | 0.53% | New | Q4 2025 | |
| $36.6M | 3.04% | 6.96% | +46.7% | Q3 2025 | |
| $35.6M | 2.96% | 1.14% | +93.0% | Q1 2025 | |
| $35.2M | 2.92% | 2.19% | -7.6% | Q3 2025 | |
| $33.7M | 2.80% | Not reported | +38.2% | Q2 2025 | |
| $33.7M | 2.80% | 1.20% | +15.5% | Q2 2023 | |
| $33.2M | 2.76% | 0.43% | +66.7% | Q2 2013 | |
| $32.9M | 2.73% | 0.85% | -6.6% | Q1 2025 | |
| $31M | 2.57% | 0.59% | +16.6% | Q3 2025 | |
| $30.4M | 2.52% | 2.81% | Not reported | Q2 2025 | |
| $27.2M | 2.26% | 0.05% | New | Q4 2025 | |
| $25.6M | 2.12% | 0.33% | +28.4% | Q2 2022 | |
| $25M | 2.07% | 0.03% | -11.1% | Q2 2024 | |
| $23.3M | 1.93% | 1.52% | +57.8% | Q2 2022 | |
| $22M | 1.83% | 0.02% | New | Q4 2025 | |
| $20.8M | 1.73% | 0.23% | -32.6% | Q3 2023 | |
| $20.4M | 1.70% | 0.34% | -21.9% | Q3 2025 | |
| $19.2M | 1.60% | 0.03% | -71.0% | Q4 2019 | |
| $18.6M | 1.54% | 0.20% | -25.6% | Q4 2024 | |
| $16.4M | 1.36% | 0.34% | +145.4% | Q3 2025 | |
| $13M | 1.08% | 0.90% | +6.4% | Q3 2019 | |
| $12.1M | 1.01% | 0.00% | New | Q4 2025 | |
| $11.7M | 0.97% | 0.01% | New | Q4 2025 | |
| $11.6M | 0.97% | 0.23% | New | Q4 2025 | |
| $11.3M | 0.94% | 0.23% | -53.6% | Q3 2020 | |
| $11M | 0.91% | 0.15% | -35.1% | Q2 2025 | |
| $10.8M | 0.90% | 1.97% | Not reported | Q3 2025 | |
| $8.97M | 0.75% | 0.76% | +11.1% | Q1 2025 | |
| $8.85M | 0.73% | 0.87% | -42.3% | Q2 2020 | |
| $8.16M | 0.68% | 0.54% | New | Q4 2025 | |
| $7.74M | 0.64% | 0.30% | New | Q4 2025 | |
| $7.3M | 0.61% | 0.12% | -47.0% | Q4 2023 | |
| $6.98M | 0.58% | 0.07% | -72.9% | Q3 2025 | |
| $6.54M | 0.54% | 0.15% | Not reported | Q3 2025 | |
| $4.49M | 0.37% | 0.76% | +263.3% | Q3 2025 | |
| TBTBPHTheravance Biopharma, Inc. | $3.4M | 0.28% | 0.36% | -85.9% | Q1 2022 |
| $2.75M | 0.23% | 0.03% | -83.1% | Q1 2018 | |
| $1.7M | 0.14% | 2.75% | New | Q4 2025 | |
| $144K | 0.01% | Not reported | Not reported | Q3 2023 | |
| Q3 2025Reported Nov 14, 202543 positions | |||||
| $72.9M | 6.14% | 0.00% | +76.5% | Q2 2025 | |
| $72.4M | 6.10% | 0.16% | +90.0% | Q2 2025 | |
| $62.7M | 5.29% | 0.00% | +13.9% | Q4 2023 | |
| $62.2M | 5.24% | 0.29% | +114.6% | Q2 2019 | |
| $61.6M | 5.19% | Not reported | Not reported | Q1 2024 | |
| $46.2M | 3.89% | 0.11% | -45.0% | Q4 2019 | |
| $42.7M | 3.59% | 0.53% | New | Q3 2025 | |
| $36.6M | 3.09% | 1.78% | +13.2% | Q1 2021 | |
| $35.4M | 2.98% | 0.43% | New | Q3 2025 | |
| $35.2M | 2.96% | 1.04% | +20.3% | Q2 2023 | |
| $33.3M | 2.81% | Not reported | -14.9% | Q2 2025 | |
| $32.1M | 2.70% | 0.34% | -36.9% | Q3 2023 | |
| $32M | 2.69% | Not reported | New | Q3 2025 | |
| LWLNWOLight & Wonder, Inc. | $31.1M | 2.62% | 0.45% | +362.7% | Q4 2013 |
| $31M | 2.61% | 4.74% | New | Q3 2025 | |
| $27M | 2.27% | 0.03% | -56.3% | Q2 2024 | |
| $25.7M | 2.17% | 0.90% | +49.3% | Q1 2025 | |
| $24M | 2.02% | 0.51% | New | Q3 2025 | |
| $22M | 1.86% | Not reported | -40.0% | Q4 2022 | |
| $21.9M | 1.84% | 0.26% | -67.3% | Q4 2024 | |
| $21.3M | 1.80% | 1.51% | -19.2% | Q2 2020 | |
| $21.2M | 1.79% | 0.48% | -48.8% | Q3 2020 | |
| $20.5M | 1.72% | 0.26% | -0.3% | Q2 2022 | |
| $19.8M | 1.67% | 0.58% | -29.2% | Q1 2025 | |
| $19M | 1.60% | 0.09% | -37.9% | Q3 2024 | |
| $19M | 1.60% | 0.25% | -52.4% | Q2 2013 | |
| TBTBPHTheravance Biopharma, Inc. | $18.7M | 1.58% | 2.53% | -28.6% | Q1 2022 |
| $18.6M | 1.57% | 2.39% | New | Q3 2025 | |
| $15.2M | 1.28% | 0.86% | -1.2% | Q3 2019 | |
| $13.7M | 1.16% | 0.04% | -38.8% | Q2 2020 | |
| $13.6M | 1.15% | 0.20% | -56.6% | Q1 2018 | |
| $13.4M | 1.13% | 0.25% | -45.9% | Q2 2025 | |
| $12.7M | 1.07% | 0.97% | -43.4% | Q2 2022 | |
| $10.4M | 0.88% | 0.22% | -83.3% | Q4 2023 | |
| $8.41M | 0.71% | 1.98% | New | Q3 2025 | |
| $7.43M | 0.63% | 0.09% | New | Q3 2025 | |
| $7.39M | 0.62% | 0.15% | New | Q3 2025 | |
| $7.34M | 0.62% | 0.69% | -53.4% | Q1 2025 | |
| $6.62M | 0.56% | 0.13% | New | Q3 2025 | |
| $6.21M | 0.52% | 0.65% | New | Q3 2025 | |
| $2.58M | 0.22% | 0.15% | New | Q3 2025 | |
| $2.21M | 0.19% | 0.21% | New | Q3 2025 | |
| $159K | 0.01% | Not reported | Not reported | Q3 2023 | |
Premium opens every quarter this fund has filed